TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE Drug Patent Profile
✉ Email this page to a colleague
When do Testosterone Cypionate-estradiol Cypionate patents expire, and when can generic versions of Testosterone Cypionate-estradiol Cypionate launch?
Testosterone Cypionate-estradiol Cypionate is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE?
- What are the global sales for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE?
- What is Average Wholesale Price for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE?
Summary for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Clinical Trials: | 2 |
DailyMed Link: | TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE at DailyMed |
Recent Clinical Trials for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
Sidney Kimmel Comprehensive Cancer Center | Phase 2 |
Baylor College of Medicine | Phase 1 |
See all TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE clinical trials
US Patents and Regulatory Information for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE | estradiol cypionate; testosterone cypionate | INJECTABLE;INJECTION | 085603-001 | Mar 13, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |